Severe asthma can cause people to live in a way to avoid worsening symptoms. Patients facing the challenges of self-management may not understand differences in treatment response or why some treatments can become less effective over time. This can lead to a patient actively deciding not to use treatment or not to follow treatment recommendations, making asthma control more difficult. New agents for severe asthma can help patients better manage their asthma.
Join us for the interactive education, “Breathe Easier with Severe Asthma: The Role of Current and Future Therapies in Reducing Exacerbations and Gaining Control of Your Symptoms.” An expert allergist-immunologist, a patient with asthma, and a representative from the Asthma and Allergy Foundation of America discuss multiple drivers involved in asthma inflammation, current management strategies, and the role of newly available biologic injectable therapies (treatments that use substances made from living organisms to treat disease).
Among the topics discussed include:
- How to reduce asthma triggers in your home
- Asthma inflammatory subtypes
- Epithelium alarmins and their role in asthma
- What is a cytokine cascade?
- What is inflammatory cycle?
- What will my HCP do to identify the asthma phenotype I have?
- How do I know if I qualify for a new agent, like tezepelumab?
- Side effects of new therapies